Burkitt Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Burkitt Lymphoma
  • +4 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Recruiting
  • Lymphoma
  • +3 more
  • obinutuzumab
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Recruiting
  • Lymphoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Active, not recruiting
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-03-31
Mar 31, 2022
D
Active, not recruiting
  • Burkitt Lymphoma
  • +2 more
  • mNavigator
  • Mwanza, Lake Zone, Tanzania
    Bugando Medical Centre
2022-03-07
Mar 7, 2022
C
Recruiting
  • Acute Leukemia
  • +7 more
  • CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
2022-03-21
Mar 21, 2022
F
Recruiting
  • Acute Leukemia
  • +18 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-16
Mar 16, 2022
F
Recruiting
  • Burkitt Lymphoma
  • +2 more
  • Rituximab and Hyaluronidase Human
  • +8 more
  • Kampala, Uganda
    UCI-Fred Hutch Cancer Centre
2022-03-09
Mar 9, 2022
M
Not yet recruiting
  • B-cell Lymphoma
  • Burkitt Lymphoma
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
2022-03-06
Mar 6, 2022
C
Not yet recruiting
  • High-grade B-cell Lymphoma
  • +8 more
  • Sepantronium Bromide
  • Busan, Korea, Republic of
  • +5 more
2022-02-27
Feb 27, 2022
U
Active, not recruiting
  • Classical Hodgkin Lymphoma
  • +12 more
    • Bedford, Bedfordshire, United Kingdom
    • +8 more
    2022-02-22
    Feb 22, 2022
    V
    Recruiting
    • Chronic Lymphocytic Leukemia
    • +11 more
    • Zilovertamab vedotin
    • Duarte, California
    • +13 more
    2022-02-08
    Feb 8, 2022
    F
    Terminated
    • Acute Biphenotypic Leukemia
    • +29 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    2022-01-24
    Jan 24, 2022
    H
    Recruiting
    • Acute Myeloid Leukemia
    • +17 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center & Research Institute
    2022-01-26
    Jan 26, 2022
    M
    Completed
    • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
    • +5 more
    • Hematopoietic Umbilical Cord Blood Stem Cell Transplantation
    • GVHD prophylaxis
    • Duarte, California
    • +15 more
    2021-11-02
    Nov 2, 2021
    N
    Recruiting
    • B-cell Lymphoma
    • +8 more
    • Polatuzumab vedotin
    • Valhalla, New York
      New York Medical Center
    2021-10-29
    Oct 29, 2021
    F
    Recruiting
    • Burkitt Lymphoma
    • OBSERVATIONAL
    • Ouagadougou, Burkina Faso
    • +6 more
    2021-10-26
    Oct 26, 2021
    W
    Recruiting
    • Diffuse Large B Cell Lymphoma
    • +4 more
    • BTK inhibitor+ Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
    • Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
    • Wuhan, Hubei, China
      Union Hospital, Huazhong University of Science and Technology
    2021-10-13
    Oct 13, 2021
    C
    Active, not recruiting
    • Anaplastic Large Cell Lymphoma
    • +4 more
    • Laboratory Biomarker Analysis
    • Questionnaire Administration
    • Birmingham, Alabama
    • +106 more
    2021-09-02
    Sep 2, 2021
    N
    Recruiting
    • Non-Hodgkin Lymphoma
    • +5 more
    • Valhalla, New York
      New York Medical College
    2021-09-01
    Sep 1, 2021
    C
    Recruiting
    • Refractory Non-Hodgkin Lymphoma
    • +8 more
    • San Francisco, California
      University of California, San Francisco
    2021-08-20
    Aug 20, 2021
    C
    Completed
    • Adult Solid Tumor
    • +2 more
    • Sutton, London, United Kingdom
    • +5 more
    2021-08-16
    Aug 16, 2021
    M
    Active, not recruiting
    • Acute Myeloid Leukemia
    • +10 more
    • Fludarabine (FLU)
    • +8 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    2021-08-13
    Aug 13, 2021